RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.
[EN] We describe herein a sensor containing nanoporous anodic alumina (NAA) as sensing platform to identify SARSCOV-2 RNA using a gating mechanism. The system is based on NAA that contains a fluorescent dye (Rhodamine B; RhB) and is capped with an oligonucleotide sequence that hybridize specifically a region of SARS-CoV-2 genome. In the presence of RNA from SARS-COV-2 virus, the oligonucleotide of the surface is displaced, uncapping the pores, and producing a delivery of RhB. The detection of the virus is achieved measuring the fluorescence of the fluorophore. The nanosensor demonstrates to be highly sensitive and selective in aqueous buffers and in biological media, having a limit of detection (LOD) of 50 ± 30 copies mL-1 of SARS-CoV-2 RNA extracted from patients. Moreover, preliminary results using 18 real nasopharyngeal swab samples indicate the potential of the system to differentiate between infected and non-infected patients. Compared to the conventional RT-PCR method, in our system there is no need for sample pretreatment or RNA isolation, providing diagnostic outcomes within 60 mins while maintaining a high level of reliability, This study was sponsored by the Spanish Government (projects
PID2021-126304OB-C41 (DOROTHY), PID2021-128141OB-C22
(ANTIVIBEM), and PID2021-122875OB-100 (MCUI/AEI/ FEDER,
UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/
2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat
Polit`ecnica de Val`encia− Instituto de Investigacion ¿ Sanitaria La Fe (IISLaFe) (SARS-COV-2-SEEKER and VISION-COV projects). This research
project has received funding from the European Union s HORIZON-CL4-
2022 research and innovation programme under grant agreement ID
101093042, PHOTONGATE project. Funded by the European Union.
Views and opinions expressed are however those of the author(s) only
and do not necessarily reflect those of the European Union or European
Research Council. Neither the European Union nor th e granting authority can be held responsible for them. This work was supported by the
European Research Council (ERC) via Advanced Grant (101052997, EDISON). Also, the project has received funding from the European
Union s HORIZON-CL4-2022 research and innovation programme
under grant agreement ID 101093042, PHOTONGATE project. A.L.P.
thanks the Ministerio de Universidades for his predoctoral grant
(FPU20/05297). E. C. thanks the Instituto de Salud Carlos III (Miguel
Servet 2023 CP23/00086). Scheme 1 was done with BioRender.com.
The Medicaments Research Ethics Committee, CEIm of University and
Polytechnic La Fe Hospital of Valencia (2021-012-1) approved the use of
samples from human patients.
Project:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-122875OB-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126304OB-C41
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-128141OB-C22
,
European Commission / HE 101052997
,
European Commission / HE 101093042
,
Generalitat Valenciana CIPROM/2021/007
,
Instituto de Salud Carlos III CP23/00086
,
Ministerio de Universidades FPU20/05297